Kronos Bio KRON

$ 0.87 1.66%

Quarterly report 2024-Q3
added 11-13-2024

Kronos Bio Balance Sheet 2011-2024 | KRON

Annual Balance Sheet Kronos Bio

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-36.1 M	-44.9 M	-165 M	-216 M	-32 M	-9.46 M	-	-	-	-	-	-	-
Long Term Debt	25.4 M	28.7 M	31.7 M	31.1 M	-	-	-	-	-	-	-	-	-
Long Term Debt Current	2.89 M	2.35 M	2.11 M	937 K	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	33.6 M	123 M	18.6 M	-	-	-	-	-	-	-
Total Current Liabilities	24.7 M	21.5 M	13.6 M	12.9 M	-	-	-	-	-	-	-	-	-
Total Liabilities	54.2 M	50.4 M	46.4 M	46.4 M	126 M	19.9 M	-	-	-	-	-	-	-
Deferred Revenue	9.58 M	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-509 M	-396 M	-263 M	-	-23.5 M	-7.34 M	-	-	-	-	-	-	-
Total Assets	213 M	295 M	391 M	512 M	103 M	12.6 M	-	-	-	-	-	-	-
Cash and Cash Equivalents	64.3 M	76 M	198 M	248 M	32.6 M	10.2 M	-	-	-	-	-	-	-
Book Value	159 M	244 M	345 M	466 M	-23.2 M	-7.3 M	-	-	-	-	-	-	-
Total Shareholders Equity	159 M	244 M	345 M	466 M	-23.2 M	-7.3 M	-	-	-	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet Kronos Bio

	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	22.5 M	23.5 M	24.5 M	25.4 M	26.3 M	27.1 M	27.9 M	28.7 M	29.5 M	-	31 M	31.7 M	32.3 M	32.8 M	29.4 M	-	-	31.1 M	31.1 M	5 K	5 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	38.9 M	41.1 M	46 M	54.2 M	59.4 M	57.3 M	63.4 M	50.4 M	50 M	-	48.8 M	46.4 M	48.5 M	47.6 M	42.7 M	46.4 M	46.4 M	46.4 M	46.4 M	2.98 M	2.98 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	5.16 M	7.53 M	8.67 M	9.58 M	8.58 M	8.82 M	8.66 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-569 M	-555 M	-539 M	-509 M	-484 M	-452 M	-422 M	-396 M	-364 M	-	-299 M	-263 M	-201 M	-167 M	-138 M	-112 M	-112 M	-112 M	-112 M	-23.5 M	-23.5 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	150 M	164 M	183 M	213 M	238 M	261 M	289 M	295 M	318 M	-	366 M	391 M	448 M	472 M	488 M	512 M	512 M	512 M	512 M	103 M	103 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	75 M	70.2 M	46.2 M	64.3 M	57.6 M	44.4 M	61.6 M	76 M	67.5 M	86.1 M	149 M	198 M	217 M	186 M	141 M	248 M	248 M	248 M	248 M	32.6 M	32.6 M	-	-	10.2 M	-	-	-	1.52 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	111 M	123 M	137 M	159 M	179 M	203 M	226 M	244 M	268 M	-	317 M	345 M	399 M	424 M	445 M	466 M	466 M	466 M	466 M	99.7 M	99.7 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	111 M	123 M	137 M	159 M	179 M	203 M	226 M	244 M	268 M	292 M	317 M	345 M	399 M	424 M	445 M	466 M	466 M	466 M	466 M	-23.2 M	-23.2 M	-13.9 M	-10.4 M	-7.3 M	-	-	-	-610 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency